tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MNPR Stock Latest News

Buy Rating for Monopar Therapeutics Inc. Driven by Strategic Acquisition and ALXN1840 Potential
RatingsBuy Rating for Monopar Therapeutics Inc. Driven by Strategic Acquisition and ALXN1840 Potential
12d ago
MNPR
Monopar Therapeutics assumed with an Overweight at Piper Sandler
PremiumThe Fly
Monopar Therapeutics assumed with an Overweight at Piper Sandler
12d ago
MNPR
Is MNPR a Buy, Before Earnings?
PremiumPre-Earnings
Is MNPR a Buy, Before Earnings?
13d ago
MNPR
Monopar Therapeutics Appoints Quan Vu as New CFO
PremiumCompany Announcements
Monopar Therapeutics Appoints Quan Vu as New CFO
27d ago
8K
MNPR
Monopar Therapeutics Appoints Lavina Talukdar to Board
PremiumCompany Announcements
Monopar Therapeutics Appoints Lavina Talukdar to Board
1M ago
8K
MNPR
Monopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright
PremiumThe FlyMonopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright
2M ago
MNPR
Monopar Therapeutics files to sell 882,761 shares of common stock for holders
Premium
The Fly
Monopar Therapeutics files to sell 882,761 shares of common stock for holders
2M ago
MNPR
Monopar Therapeutics initiated with an Overweight at Piper Sandler
Premium
The Fly
Monopar Therapeutics initiated with an Overweight at Piper Sandler
3M ago
MNPR
These 2 Monster Growth Stocks Skyrocketed Over 1,000% This Year — Here’s What Analysts Expect in 2025
PremiumStock Analysis & Ideas
These 2 Monster Growth Stocks Skyrocketed Over 1,000% This Year — Here’s What Analysts Expect in 2025
3M ago
DAVE
MNPR
Monopar Therapeutics prices 798,655 shares at $23.79 in registered offering
PremiumThe Fly
Monopar Therapeutics prices 798,655 shares at $23.79 in registered offering
3M ago
MNPR
Monopar Therapeutics Achieves Milestone in Cancer Treatment
PremiumCompany Announcements
Monopar Therapeutics Achieves Milestone in Cancer Treatment
4M ago
8K
MNPR
Monopar Therapeutics doses first patient with MNPR-101-Lu
PremiumThe Fly
Monopar Therapeutics doses first patient with MNPR-101-Lu
4M ago
MNPR
Monopar Therapeutics price target raised to $37 from $9 at JonesResearch
PremiumThe FlyMonopar Therapeutics price target raised to $37 from $9 at JonesResearch
4M ago
MNPR
Monopar Therapeutics price target raised to $22 from $6 at H.C. Wainwright
Premium
The Fly
Monopar Therapeutics price target raised to $22 from $6 at H.C. Wainwright
5M ago
MNPR
Monopar Therapeutics reports Q3 EPS (37c), consensus (48c)
Premium
The Fly
Monopar Therapeutics reports Q3 EPS (37c), consensus (48c)
5M ago
MNPR
Monopar Therapeutics Closes $19.2 Million Stock Offering
PremiumCompany Announcements
Monopar Therapeutics Closes $19.2 Million Stock Offering
5M ago
8K
MNPR
Monopar Therapeutics 1.16M share Spot Secondary priced at $16.25
PremiumThe Fly
Monopar Therapeutics 1.16M share Spot Secondary priced at $16.25
5M ago
MNPR
Monopar Therapeutics announces common stock offering, no amount given
PremiumThe Fly
Monopar Therapeutics announces common stock offering, no amount given
5M ago
MNPR
Monopar Therapeutics Secures License for Wilson Disease Treatment
PremiumCompany Announcements
Monopar Therapeutics Secures License for Wilson Disease Treatment
5M ago
8K
MNPR
Monopar Therapeutics enters agreement with Alexion, AstraZeneca Rare Disease
PremiumThe FlyMonopar Therapeutics enters agreement with Alexion, AstraZeneca Rare Disease
5M ago
MNPR
Monopar Therapeutics Unveils Promising Radiopharmaceutical Data
Premium
Company Announcements
Monopar Therapeutics Unveils Promising Radiopharmaceutical Data
5M ago
8K
MNPR
Monopar Therapeutics presents data from radiopharma program based on MNPR-101
Premium
The Fly
Monopar Therapeutics presents data from radiopharma program based on MNPR-101
5M ago
MNPR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >